Group currently is comprised of 12 subsidiary businesses in the technology and life sciences sectors based upon 
• On 13 March 2017, the Company appointed Jill Smith, formerly a Non-Executive Director, as interim CEO.
• Group Subsidiary Ownership Adjusted Value (GSOAV) of $395.6 million as of 22 March 2018 
Allied Minds sources, operates and funds a portfolio of subsidiary companies to generate long-term value for its 
we provide an overview of our 12 current operating subsidiary businesses, including year formed, and Allied 
At the close of each annual financial period, the Directors formally approve the value of all subsidiary businesses 
• Change in Group Subsidiary Ownership Adjusted Value (GSOAV); and
Significant performance-impacting events and business developments reflected in the Company’s financial 
• Each subsidiary business holds quarterly board of director meetings, with participation from the Group’s 
impact the financial return to the Group on its investment in the applicable subsidiary businesses.
international business leader, including 16 years as Chief Executive Officer of private and public companies in 
share capital of the Company are as shown in the Directors’ Remuneration Report on page 92.
financial or commercial prospects or performance of the Group’s individual subsidiary companies, the ability to 
information on the Group’s financial risk management objectives and policies, including those in relation to 
The Directors are responsible for preparing the Annual Report and Accounts and the Group and parent Company 
Company law requires the Directors to prepare Group and parent Company financial statements for each 
In preparing each of the Group and parent Company financial statements, the Directors are required to:
• assess the Group and parent Company’s ability to continue as a going concern, disclosing, as applicable, 
site visits to a number of the Group’s subsidiary companies, which will include meeting with such companies’ 
includes an overview of the activities of the Group, details of its subsidiary companies and its key university and 
• Conducted a review of all elements of remuneration for Executive Directors and senior management, including 
• Determined the cash incentive bonus awards for the Executive Officers for the last financial year;
• Established 2015, 2016 and 2017 LTIP award performance targets for the current financial year; and 71
In addition to the Executive Directors’ remuneration arrangements set forth in the Remuneration Policy, the Group 
(3)  Equities based payments in 2016 include the value of LTIP awards granted to the Executive Directors in 2014 which vested in June 2017 
Equities based payments in 2017 include the value of LTIP awards granted to the Executive Directors in 2015 which are expected to vest in 
Equities based payments also include the value of LTIP awards granted to the Non-Executive Directors that vested in 2016 and 2017 (based 
• 60% of each award was subject to performance conditions based on the Company’s total shareholder return 
• 60% of each award will be subject to performance conditions based on the Company’s total shareholder 
2016, the Remuneration Committee adopted a share ownership policy for Executive Directors.
• Change in Group Subsidiary Ownership Adjusted Value (GSOAV) taken from page 16.
• an annual incentive award equal to the product of: (A) the Executive Directors bonus for the prior year; and 
• Set the management by objectives (MBOs), including financial, operational, technical and other performance 
• Review the Company’s internal financial controls and the Company’s internal control and risk management 
The Committee carries out these duties for the Company, major subsidiary undertakings and the Group as a 
• Considered significant matters, risk areas, and areas of judgement in relation to the Group’s financial 
At the close of each annual financial period, the Directors formally approve the value of all subsidiary businesses 
included in the Group’s Consolidated Statement of Financial Position, additional disclosures are provided in the 
–  the parent Company financial statements and the part of the Directors’ Remuneration Report to be audited 
The group financial statements consolidate those of the Company and 
The consolidated financial statements include the Group’s share of the total comprehensive income and 
The Group’s financial liabilities include subsidiary preferred shares some of which incorporate embedded 
• they include no contractual obligations upon the Group to deliver cash or other financial assets or to exchange 
Share-based payment arrangements in which the Group or its subsidiaries receive goods or services as consideration 
Whilst the Group includes RF Biocidics (UK) Limited, which is a UK company, the revenues and net operating 
officers and Directors, and other individuals providing services to the Company and its subsidiaries.
• awards subject to performance conditions based on the Company’s total shareholder return (“TSR”) 
2017 the capitalisation of all subsidiary companies in the Group portfolio is in the form of ordinary shares only, 
B preferred shares for $42.0 million to Allied Minds, existing shareholders of the Group, and a number of new 
Capital and as such the subsidiary will continue to be fully consolidated within the group’s financial statements.
The following tables summarise the financial information related to the Group’s subsidiaries with material non-
At the close of each annual financial period, the Directors formally approve the value of all subsidiary businesses 
In the current year, the Group relied on funding transactions as the principal methodology to value all subsidiaries 
For the two years ended 31 December 2017, the Group recognised the following changes in subsidiary 
• Costs and capital expenditures are estimated for each phase of development based on the companies’ 
inputs used in the fair value measurement of the Group’s subsidiary preferred shares liability, as well as that in 
For assumptions used in the fair value measurement of the Group’s subsidiary preferred shares liability designated 
The Group’s executive management and board of directors have overall responsibility for establishment and 
Share-based payments include the value of awards granted under the LTIP during the year.
Executive management and Directors of the Company control 0.2% of the voting shares of the Company as of 
The remuneration of the Directors of the Company is disclosed in note 24 to the consolidated financial statements.